It is not approved for clinical use
"Although BPC 157 was discovered in the early 1990s, there is still no adequate data about its safety or effectiveness." Opponents, however, are worried about the lack of research to back up the health claims and the safety risks that untested injections pose to patients
The formulation takes a multi-peptide approach rather than focusing exclusively on GHK-Cu
While the concentration of research within a single group has drawn some scientific criticism regarding independent verification, it has also produced an unusually coherent and detailed body of knowledge about a single compound
Consistency is key to seeing results, as skin regeneration is a gradual process
Kit contents, timing, and use instructions are provided only after approval and should be followed exactly as directed by the clinician